Forehead tissue expander.

W H Kisner

Home/Archive/PubMed

PubMed · 2041042

Forehead tissue expander.

W H Kisner

View original source ↗Export metadata ↓

Abstract

The use of the forehead flap for nasal reconstruction has long been used by reconstructive surgeons. A case is presented in which comprised forehead skin is utilized following expansion by a tissue expander.

Explore related subjects

Basal Cell Carcinoma Female Forehead Humans Neoplasm Recurrence, Local Nose Neoplasms Surgical Flaps Tissue Expansion Devices Case Reports Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

W H Kisner. 1991. Forehead tissue expander.. https://pubmed.ncbi.nlm.nih.gov/2041042/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

The sebaceous nevus: a nevus with deletions of the PTCH gene.

Sebaceous nevi (SN) are congenital malformations of the skin with the potential to develop into basal cell carcinoma (BCC). To date, the molecular basis for their carcinogenic potential remains unknown. The genetic defect in BCC is known and involves the human homologue of Drosophila patched (PTCH) on chromosome 9q22.3. The objective of this study was to test whether allelic deletion of the PTCH gene could already be detected in SN. Twenty-one paraffin-embedded SN were investigated in this study. Basaloid cells in conjunction with mature sebaceous glands as well as epidermal layer apart from SN were microdissected and subjected to single-step DNA extraction. We performed the analysis with polymorphic markers at 9q22.3 (D9S15, D9S252, D9S287, and D9S303). Of the 20 informative SN, 8 (40%) exhibited loss of heterozygosity at least at one locus. Here, we provide the first evidence of the involvement of the tumor suppressor gene PTCH in SN. Whether PTCH deletion in SN is associated with progression to BCC and/or other appendageal tumors should be addressed in future studies.

Basal Cell Carcinoma↗

PubMed1999

[Skin carcinogenesis].

Two main distinct subtypes of epithelial skin cancers can be distinguished, both arising from keratinocytes, most frequently at sun-exposed body sites. Basal cell carcinomas (BCC) grow slowly, nearly never metastases, whereas squamous carcinomas (SCC) are locally more invasive tumors, which have a greater metastatic potential. Skin carcinogenesis is a multiple step process, in which UV light play a major role. Numerous genetic lesions occur, either inactivating tumor suppressor genes (which normally repress cell growth), or activating oncogenes (which promote cellular multiplication). The most important tumor suppressor gene involved in both skin neoplasms is p53, which is inactivated in 40-50% of cases, by specific UV induced mutations. Yet, some differences exist between these two subtypes, which could explain their difference in invasiveness.

Basal Cell Carcinoma↗

PubMed1999

[Basal cell carcinoma].

Basal cell carcinoma is the most frequent of all cancers. Its incidence has risen those last decades because of the increase in sun exposure habits. People with light skin complexion are particularly at risk. Ionizing radiations, arsenicism, various genodermatoses (Gorlin syndrome, xeroderma pigmentosum, nevus sebaceous) are other pre-disposing factors. Basal cell carcinoma usually present as small lesion with a pearly border and telangiectasias. Other clinical types must also be recognized such as the nodular, the infiltrative, the superficial and the pigmented forms. They are usually located on the head and trunk. The prognosis of basal cell carcinoma is usually good since they can be cured by surgical excision and because they usually do not metastasize. However, large, multiple or recurrent basal cell carcinomas can be difficult to treat. In these cases, cryosurgery, radiotherapy or intralesional interferon-alfa may be needed.

Basal Cell Carcinoma↗